These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36456068)

  • 1. Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device.
    Mehra MR; Nayak A; Morris AA; Lanfear DE; Nemeh H; Desai S; Bansal A; Guerrero-Miranda C; Hall S; Cleveland JC; Goldstein DJ; Uriel N; Chen L; Bailey S; Anyanwu A; Heatley G; Chuang J; Estep JD
    JACC Heart Fail; 2022 Dec; 10(12):948-959. PubMed ID: 36456068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    Nayak A; Hall SA; Uriel N; Goldstein DJ; Cleveland JC; Cowger JA; Salerno CT; Naka Y; Horstmanshof D; Crandall D; Wang A; Mehra MR
    J Am Coll Cardiol; 2023 Aug; 82(9):771-781. PubMed ID: 37612008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
    John R; Kanwar MK; Cleveland JC; Uriel N; Naka Y; Salerno C; Horstmanshof D; Hall SA; Cowger JA; Heatley G; Somo SI; Mehra MR
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1684-1694.e18. PubMed ID: 35643769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
    Uriel N; Milano C; Agarwal R; Lee S; Cleveland J; Goldstein D; Wang A; Crandall D; Mehra MR
    Eur J Heart Fail; 2023 Feb; 25(2):286-294. PubMed ID: 36404406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter evaluation of the HeartMate 3 risk score.
    Grewal J; Tripathi N; Bortner B; Gregoski MJ; Cook D; Britt A; Hajj J; Rofael M; Sheidu M; Montovano MJ; Mehta M; Hajduczok AG; Rajapreyar IN; Brailovsky Y; Genuardi MV; Kanwar MK; Atluri P; Lander M; Shah P; Hsu S; Kilic A; Houston BA; Mehra MR; Sheikh FH; Tedford RJ
    J Heart Lung Transplant; 2024 Apr; 43(4):626-632. PubMed ID: 38061468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
    Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
    Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
    JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
    Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
    J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men.
    Ramu B; Cogswell R; Ravichandran AK; Cleveland J; Mehra MR; Goldstein D; Uriel N; Dirckx N; Ahmed S; Yuzefpolskaya M
    JACC Heart Fail; 2023 Dec; 11(12):1692-1704. PubMed ID: 37831046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
    Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
    Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
    Mehra MR; Cleveland JC; Uriel N; Cowger JA; Hall S; Horstmanshof D; Naka Y; Salerno CT; Chuang J; Williams C; Goldstein DJ;
    Eur J Heart Fail; 2021 Aug; 23(8):1392-1400. PubMed ID: 33932272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.
    Heatley G; Sood P; Goldstein D; Uriel N; Cleveland J; Middlebrook D; Mehra MR;
    J Heart Lung Transplant; 2016 Apr; 35(4):528-36. PubMed ID: 27044532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.
    Mehra MR; Goldstein DJ; Cleveland JC; Cowger JA; Hall S; Salerno CT; Naka Y; Horstmanshof D; Chuang J; Wang A; Uriel N
    JAMA; 2022 Sep; 328(12):1233-1242. PubMed ID: 36074476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of right ventricular failure after continuous flow left ventricular assist device implantation.
    Sert DE; Karahan M; Aygun E; Kocabeyoglu SS; Akdi M; Kervan U
    J Card Surg; 2020 Nov; 35(11):2965-2973. PubMed ID: 32803812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
    Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
    Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation and Validation of a Novel Sex-Specific Mortality Risk Score in LVAD Recipients.
    Nayak A; Hu Y; Ko YA; Steinberg R; Das S; Mehta A; Liu C; Pennington J; Xie R; Kirklin JK; Kormos RL; Cowger J; Simon MA; Morris AA
    J Am Heart Assoc; 2021 Apr; 10(7):e020019. PubMed ID: 33764158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Predictors of Late Right Heart Failure After Left Ventricular Assist Device Implantation.
    Alkhunaizi FA; Azih NI; Read JM; Goldberg RL; Gulati AA; Scheel PJ; Muslem R; Gilotra NA; Sharma K; Kilic A; Houston BA; Tedford RJ; Hsu S
    ASAIO J; 2023 Mar; 69(3):315-323. PubMed ID: 36191552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.